CSL USA INC. opens new fermentation facility to produce food ingredients and cultures, bacterial cultures, and probiotics for use in dairy, food, dietary supplements, pharma, and agriculture.
Franksville, Wisconsin, USA: Today, CSL USA INC. (Cultures Supporting Life), an independent entity, is born with the intention of offering new technology solutions to meet the growing needs of the US biotechnology market. CSL USA announces the opening of its new custom fermentation facility, located in Franksville, Wisconsin. The 80,000 sq. ft. facility will support the growing Food, Beverage, Health, and Nutrition markets.
CSL USA will have access to strains and technologies developed by Sacco System (Milan, Italy) over its 150 years of history.
Sacco System produces food ingredients including food cultures, bacterial cultures, and probiotics, for the dairy, food, dietary supplements, pharma, and agriculture markets since 1872. Sacco System is also one of the largest contract fermentation organizations in the world.
As an official technology partner to Sacco System, CSL USA enters the market with a strong platform of science and a long history of fermentation experience. CSL USA will promote the full line of food ingredients, food cultures, bacterial cultures, probiotics, and comprehensive fermentation services to customers in the US. This business association will provide mutual benefits to CSL USA and Sacco System, and most importantly, to our customers today and long into the future.
Kyle Griffiths, Vice President of Sales & Marketing for CSL USA said in a written statement, “The new CSL USA production facilities located in the United States will increase our flexibility to serve the needs of US customers, while increasing the global capacity for our worldwide customer base. We believe that the creation of CSL USA will accelerate our efforts to grow in both the health and nutrition and the food and beverage markets globally as we bring new products and service to the US marketplace”.
For Information contact info@cslusa.com
Latest News
An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.
The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy
El grupo acelera su estrategia de desarrollo en Sudamérica mediante una doble operación: la adquisición de una empresa uruguaya y la integración total de su filial brasileña. El grupo apunta
La leche es el recurso más valioso en la producción láctea.Solo es posible obtener productos de alta calidad a partir de leche de alta calidad, y en el panorama actual,
“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been
GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a
Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1
Our commitment to sustainability: a review of an evolving journey We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved
Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the
At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco
Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce
Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries, based on tradition, expertise, research, and innovation which sells and distributes its ingredients in more